John B. Moriarty, Chief Legal Officer at Avidity Biosciences ($RNA), made two open market sales of company shares over the past year, totaling $253,000. His latest sale occurred on January 7, 2026. These transactions rank 7,933rd among 11,678 insiders by sale value, well below the average of $8.6 million per insider across about 6.4 trades. Moriarty recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Moriarty John B | Chief Legal Officer | D | Stock Option (Right to Buy) | 160000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.11% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Moriarty John B | Chief Legal Officer | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.03% |
| Feb. 27, 2026 | Avidity Biosciences, Inc. | $RNAM | Moriarty John B | Chief Legal Officer | D | Common Stock | 92054 | $0.00 | 0.0000 | 150,675,742 | 100.00% | 0.06% |
| Jan. 7, 2026 | Avidity Biosciences, Inc. | $RNAM | Moriarty John B | Chief Legal Officer | S | Common Stock | 2374 | $72.23 | 74,557.0000 | 150,675,742 | 3.09% | 0.00% |
| Dec. 17, 2025 | Avidity Biosciences, Inc. | $RNAM | Moriarty John B | Chief Legal Officer | A | Common Stock | 56000 | $0.00 | 103,755.0000 | 150,675,742 | 117.27% | 0.04% |
| Dec. 17, 2025 | Avidity Biosciences, Inc. | $RNAM | Moriarty John B | Chief Legal Officer | F | Common Stock | 26824 | $71.87 | 76,931.0000 | 150,675,742 | 25.85% | 0.02% |
| Aug. 4, 2025 | Avidity Biosciences, Inc. | $RNAM | Moriarty John B | Chief Legal Officer | S | Common Stock | 2245 | $36.21 | 47,755.0000 | 120,212,301 | 4.49% | 0.00% |
| Jan. 6, 2025 | Avidity Biosciences, Inc. | $RNAM | Moriarty John B | Chief Legal Officer | A | Common Stock | 25000 | $0.00 | 50,000.0000 | 0 | 100.00% | 0.00% |
| Jan. 6, 2025 | Avidity Biosciences, Inc. | $RNAM | Moriarty John B | Chief Legal Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2024 | Avidity Biosciences, Inc. | $RNAM | Moriarty John B | Chief Legal Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2024 | Avidity Biosciences, Inc. | $RNAM | Moriarty John B | Chief Legal Officer | A | Common Stock | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Moriarty John B | EVP, Ch. Legal Officer & Sec. | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |